The Cardinals ended a seven-game losing streak against Milwaukee Wednesday night, winning 5-1 behind home runs from Alec Burleson and José Fermín and a sharp 6 1/3-inning start from Michael McGreevy. On its own, a series finale win is a box score item. Pair it with the Brewers confirming a new shoulder injury to Brandon Woodruff the same evening, and there's a real betting conversation to have.
What Happened in the Game
McGreevy was the story on the mound. Six-plus innings, one run allowed, which means St. Louis won this one the right way. It wasn't a bullpen scramble or a lucky bounce, it was their starter eating innings and keeping Milwaukee's offense quiet. Burleson and Fermín supplied the pop. The Cardinals scored five runs total, and a 5-1 final against a divisional rival is a controlled win, not a fluke.
For St. Louis, the streak-snapping angle matters beyond morale. Seven straight losses to one opponent inside the division is the kind of thing that warps a team's run-line and series pricing. The market had been pricing the Cardinals' matchup history against Milwaukee into the odds. That history just got a data point in the other direction.
The Woodruff News Changes the Brewers' Picture
The bigger market mover may not be Wednesday's final score. An MRI revealed a new injury to Woodruff's anterior capsule, and Milwaukee is seeking a second opinion. That is a different and more serious finding than the inflammation that had been on the books. Anterior capsule damage to a pitcher's shoulder is not a soft-tissue bruise. Second opinions get requested when the first answer is bad enough to warrant questioning it, or confirming it.
Woodruff has a history of shoulder trouble. This club already knew it was managing him carefully. A structural finding of this kind typically carries a longer runway than inflammation alone, and the Brewers now head into the second half of the season without clarity on when or whether he contributes.
What This Means for the Lines
The Cardinals' win closes out this series on a positive note for St. Louis. The sharper future impact is in Milwaukee's rotation depth and how books price Brewers team totals and series lines going forward.
| Factor | Direction | Notes |
|---|---|---|
| Cardinals vs. Brewers series price | Slight Cardinals lean | Streak over, McGreevy showed well |
| Brewers team totals | Down pressure | Rotation uncertainty without Woodruff |
| Brewers win-total futures | Depends on 2nd opinion | Structural injury vs. inflammation matters |
| Cardinals starter props | Watch McGreevy | 6.1 IP, 1 ER is a strong line to track |
My number on the Brewers' rotation situation moves meaningfully if the second opinion confirms a structural finding. Inflammation timelines are measured in weeks. Anterior capsule injuries in pitchers can run months. The market will price the difference once the second opinion lands.
For Milwaukee's win-total, I had them as a team already navigating a thinned-out starting staff. This compounds it. If you're holding Brewers futures bought earlier in the year, the Woodruff news is the thing to watch, not tonight's loss.
The Cardinals, meanwhile, get to reset the head-to-head narrative. McGreevy's performance is worth tracking as a starter prop if his next start draws a workable matchup. Six-plus innings at one run is the kind of line that moves opener markets.
What I'm Watching Next
The Brewers' second opinion on Woodruff is the number-one item on my board right now. The moment that lands, I'm mapping it against Milwaukee's upcoming rotation schedule and their team-total pricing for the next ten days. If the finding is structural, the books will adjust, but they'll need the confirmation first, and there's usually a window before the full repricing hits.
